21 -

21 - Bex A, Mallo H, Kerst M, Haanen J, Horenblas S, De Gast GC. A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumor. Cancer Immunology, Immunotherapy. 2005;54(7):713-9.